| scholarly article | Q13442814 |
| P50 | author | Sérgio Dias | Q38326072 |
| P2093 | author name string | Susana Constantino Rosa Santos | |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| acute leukemia | Q976388 | ||
| P304 | page(s) | 3883-3889 | |
| P577 | publication date | 2004-01-15 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Internal and external autocrine VEGF/KDR loops regulate survival of subsets of acute leukemia through distinct signaling pathways | |
| P478 | volume | 103 |
| Q38269954 | (Lymph)angiogenic influences on hematopoietic cells in acute myeloid leukemia |
| Q42290163 | A proangiogenic signaling axis in myeloid cells promotes malignant progression of glioma. |
| Q43181954 | A randomized phase I clinical and biologic study of two schedules of sorafenib in patients with myelodysplastic syndrome or acute myeloid leukemia: a NCIC (National Cancer Institute of Canada) Clinical Trials Group Study |
| Q89100184 | A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients |
| Q37312735 | ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside |
| Q39686603 | Aberrant autophosphorylation of c-Kit receptor in canine mast cell tumor cell lines |
| Q46990483 | Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer |
| Q40295205 | Activation of FGFR1beta signaling pathway promotes survival, migration and resistance to chemotherapy in acute myeloid leukemia cells |
| Q41313323 | Angiogenesis Status in Patients with Acute Myeloid Leukemia: From Diagnosis to Post-hematopoietic Stem Cell Transplantation |
| Q38160129 | Angiogenesis and acute myeloid leukemia |
| Q48591040 | Anti-Vascular Endothelial Growth Factor Targeting by Curcumin and Thalidomide in Acute Myeloid Leukemia Cells |
| Q33692555 | Anticancer Role of PPARgamma Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes. |
| Q47649124 | Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway |
| Q36799838 | Autocrine VEGF loops, signaling pathways, and acute leukemia regulation. |
| Q81326791 | Autocrine VEGF mediates the antiapoptotic effect of CD154 on CLL cells |
| Q34385792 | Butyrate-rich colonic microenvironment is a relevant selection factor for metabolically adapted tumor cells |
| Q80540771 | Circulating angiopoietin-2 is a strong prognostic factor in acute myeloid leukemia |
| Q30436024 | Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport |
| Q40319128 | Disease-specific expression of VEGF and its receptors in AML cells: possible autocrine pathway of VEGF/type1 receptor of VEGF in t(15;17) AML and VEGF/type2 receptor of VEGF in t(8;21) AML. |
| Q41692817 | Distinguishing autocrine and paracrine signals in hematopoietic stem cell culture using a biofunctional microcavity platform |
| Q35003666 | Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics |
| Q40196292 | Downregulation of VEGF-A, STAT5 and AKT in acute myeloid leukemia blasts of patients treated with SU5416. |
| Q43490126 | Effect of heat shock protein-90 (HSP90) and vascular endothelial growth factor (VEGF) on survival in acute lymphoblastic leukemia: an immunohistochemical study |
| Q39185508 | Effects of autocrine vascular endothelial growth factor (VEGF) in non-small cell lung cancer cell line A549. |
| Q47288480 | Effects of vascular endothelial growth factors and their receptors on megakaryocytes and platelets and related diseases |
| Q40408299 | Enforced expression of KDR receptor promotes proliferation, survival and megakaryocytic differentiation of TF1 progenitor cell line. |
| Q37426395 | Gene Expression of VEGF-A and VEGF-C in Peripheral Blood Mononuclear Cells of Iranian Patients with Acute Myeloid Leukemia |
| Q36672180 | Hemangioblasts representing a functional endothelio-hematopoietic entity in ontogeny, postnatal life, and CML neovasculogenesis |
| Q38925857 | Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1 (HS3ST3B1) promotes angiogenesis and proliferation by induction of VEGF in acute myeloid leukemia cells |
| Q34314042 | Imaging of VEGF receptor kinase inhibitor-induced antiangiogenic effects in drug-resistant human adenocarcinoma model |
| Q48128395 | Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1. |
| Q38987856 | Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cells |
| Q40463360 | Integrative meta-modeling identifies endocytic vesicles, late endosome and the nucleus as the cellular compartments primarily directing RTK signaling. |
| Q36918194 | Intracrine VEGF Signaling Mediates the Activity of Prosurvival Pathways in Human Colorectal Cancer Cells. |
| Q35574990 | Intracrine vascular endothelial growth factor signaling in survival and chemoresistance of human colorectal cancer cells |
| Q41442716 | Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV. |
| Q37169427 | Ligand-independent thrombopoietin mutant receptor requires cell surface localization for endogenous activity |
| Q92837924 | MicroRNAs and regulated interaction networks reveal differences between adult and pediatric acute myeloid leukemia |
| Q47111427 | Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells |
| Q40071740 | Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2. |
| Q40019030 | Neuropilin-1 in acute myeloid leukemia: expression and role in proliferation and migration of leukemia cells |
| Q41853468 | New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosis |
| Q33826204 | PRH/Hhex controls cell survival through coordinate transcriptional regulation of vascular endothelial growth factor signaling. |
| Q58211896 | Phosphorylated KDR expression in endometrial cancer cells relates to HIF1α/VEGF pathway and unfavourable prognosis |
| Q58211789 | Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation |
| Q40376516 | Placenta growth factor stimulates the growth of Philadelphia chromosome positive acute lymphoblastic leukemia cells by both autocrine and paracrine pathways |
| Q41869300 | Profiling of microRNAs in AML cells following overexpression or silencing of the VEGF gene |
| Q64881176 | Proteomic Profiling of Primary Human Acute Myeloid Leukemia Cells Does Not Reflect Their Constitutive Release of Soluble Mediators. |
| Q26830216 | Receptor tyrosine kinases in the nucleus |
| Q39985162 | Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma |
| Q36263918 | Soluble angiopoietin-2/sTie2 receptor ratio is an independent prognostic marker in adult acute myeloid leukemia. |
| Q42825075 | Src kinases mediate VEGFR2 transactivation by the osteostatin domain of PTHrP to modulate osteoblastic function |
| Q92138562 | Stress and catecholamines modulate the bone marrow microenvironment to promote tumorigenesis |
| Q36110555 | Survival of chronic lymphocytic leukemia cells: CD40L and the vascular endothelial growth factor (VEGF) connection |
| Q42064478 | Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells. |
| Q36290649 | Targeted Intraceptor Nanoparticle for Neovascular Macular Degeneration: Preclinical Dose Optimization and Toxicology Assessment. |
| Q42717692 | Targeted inhibition of VEGF-modulated survival and arsenic sensitivity in acute myeloid leukemia (AML). |
| Q30539153 | Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration. |
| Q38038645 | Targeting the vascular endothelial growth factor in hematologic malignancies |
| Q61797473 | The Capacity of Long-Term in Vitro Proliferation of Acute Myeloid Leukemia Cells Supported Only by Exogenous Cytokines Is Associated with a Patient Subset with Adverse Outcome |
| Q37068534 | The basis of an intracrine pharmacology |
| Q24628178 | The biology of CD44 and HCELL in hematopoiesis: the 'step 2-bypass pathway' and other emerging perspectives |
| Q38444074 | The expression and cellular localization of phosphorylated VEGFR2 in lymphoma and non-neoplastic lymphadenopathy: an immunohistochemical study |
| Q36844618 | The physiological basis of intracrine stem cell regulation |
| Q39920733 | The role of VEGF and a functional link between VEGF and p27Kip1 in acute myeloid leukemia. |
| Q64997568 | Tubeimoside-1 inhibits the proliferation and metastasis by promoting miR-126-5p expression in non-small cell lung cancer cells. |
| Q37308766 | Tumor cell expression of vascular endothelial growth factor receptor 2 is an adverse prognostic factor in patients with squamous cell carcinoma of the lung |
| Q35162649 | VEGF is essential for the growth and migration of human hepatocellular carcinoma cells |
| Q46332669 | VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance |
| Q54965419 | VEGF signaling in acute leukemia: mitochondrial connections. |
| Q43475634 | VEGF/PLGF induces leukemia cell migration via P38/ERK1/2 kinase pathway, resulting in Rho GTPases activation and caveolae formation. |
| Q34043465 | VEGFR2 translocates to the nucleus to regulate its own transcription |
| Q35569079 | Vandetanib mediates anti-leukemia activity by multiple mechanisms and interacts synergistically with DNA damaging agents |
| Q39823308 | Vascular Endothelial Growth Factor A isoform mRNA expression in pediatric acute myeloid leukemia |
| Q64965657 | Vascular Endothelial Growth Factor Directly Inhibits Primitive Neural Stem Cell Survival But Promotes Definitive Neural Stem Cell Survival |
| Q38029546 | Vascular endothelial growth factor signaling in acute myeloid leukemia |
| Q39608979 | ZFAT is a critical molecule for cell survival in mouse embryonic fibroblasts |
| Q35848196 | mTOR regulates cell survival after etoposide treatment in primary AML cells |
| Q39039867 | miR-125b promotes MLL-AF9-driven murine acute myeloid leukemia involving a VEGFA-mediated non-cell-intrinsic mechanism |
| Q54516791 | miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A. |
| Q40208269 | t(8;21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)/VEGF receptor type2 pathway and phosphorylation of Akt. |
Search more.